BioMarin Q1 2026 Earnings EPS Misses Estimates as Stock Slips Redhill Biopharma RDHL Q2 2022 Earnings Massive EPS Miss Raises Liquidity Concerns Voyager Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Response Blue Owl Capital Corporation OBDC Q1 2026 Earnings EPS Misses Estimates but Stock Posts Modest Gain VNT Q1 2026 Earnings EPS Misses Estimate by a Hair Stock Rises 246 Embraer EMBJ Rises 188 as Aerospace Sector Momentum Builds Neumora Therapeutics NMRA Holds Steady at 185 Amid Mixed Sentiment Establishment Labs ESTA Posts Modest Gain as Shares Hold Above Key Support Aris Mining ARIS Faces Resistance at 178 Support Tested at 161 WBS Q1 2026 Earnings EPS Beats Estimates as Stock Edges Lower